+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05800574

Phase II Study of Lymphoscintigraphy-Directed Neck Radiation and Chemotherapy for p16 Oropharynx Cancer with Favorable Prognosis

Led by Fox Chase Cancer Center · Updated on 2026-11-02

22

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a treatment approach for patients with p16-positive oropharynx cancer who have either no lymph node involvement or limited malignant neck adenopathy confined to one side of the neck. This phase II study aims to explore the prognosis and safety of lymphoscintigraphy-directed elective neck radiation in these patients, focusing on those with favorable risk and no spread to the opposite side of the neck. The study is designed as a single arm investigation with stratification based on extent of neck involvement. Participants will receive radiation therapy Monday through Friday for either 6 or 7 weeks, depending on their cohort. Cohort A includes patients with more extensive neck involvement or larger lymph nodes, while Cohort B includes patients with no or limited lymph node involvement. Some participants may also receive weekly Cisplatin chemotherapy. The radiation is carefully targeted using lymphoscintigraphy mapping to limit treatment to the affected side of the neck. Treatment continues for 6 to 7 weeks or until unacceptable side effects or withdrawal. During the study, participants will undergo PETCT scans to monitor for cancer progression on the opposite side of the neck. Quality of life related to dry mouth will be assessed at 6, 12, and 24 months using a standardized questionnaire. Swallowing function will be evaluated by testing and patient reports over two years. Researchers will track disease free survival and overall survival for 24 months after treatment. Participants will be closely monitored for side effects and outcomes throughout the study period.

CONDITIONS

Brief Title

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Research Team

R

Ryan Romasko

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here